POS0648 EFFICACY AND SAFETY OF LOW OR HIGH DOSE METHOTREXATE IN COMBINATION WITH ADALIMUMAB IN PATIENTS WITH ELDERLY-ONSET RHEUMATOID ARTHRITIS: RESULTS FROM THE RANDOMISED, CONTROLLED MIRACLE TRIAL
H. Tamai(Keio University), Yoko Kaneko(Keio University), T. Taninaga, Kichul Shin(Brigham and Women's Hospital), Imseung Choi, S. Sato, Y. Okano, M. Kuwana, T. T. Cheng, M. Mori, H. Kameda, C. M. Huang, Y. J. Lee, Jae‐Weon Kim(Seoul National University), Seong Ho Park(Ulsan College), T. Kojima, T. Ishii, H. Miyagishi, P. N. Hsu, Minfang Weng, H. Yasuoka, Kaori Ikeda, Tsutomu Takeuchi(Keio University), C. F. Kuo, T. Miyamoto, Y. Sato, H. Taguchi, Shu Hirata, W. C. Tsai, H. J. Baek, W. Y. Sung
Cited by 1
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|413
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update
|Radiology Artificial Intelligence|2024|406